Lenvatinib Mesylate and Tetanus and Diphtheria Vaccine
Determining the interaction of Lenvatinib Mesylate and Tetanus and Diphtheria Vaccine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: diphtheria toxoid / tetanus toxoid
Brand name: Diphtheria-Tetanus Toxoids, Pediatric, Decavac, Tenivac
Synonyms: Diphtheria and tetanus toxoids vaccine, Diphtheria and Tetanus Toxoids
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Tetanus Immune Globulin
- Lenvatinib Mesylate-Tetanus Immune Globulin (Human)
- Lenvatinib Mesylate-Tetanus immune globulin Intramuscular
- Lenvatinib Mesylate-Tetanus Toxoid (Adsorbed)
- Lenvatinib Mesylate-Tetanus toxoid Intramuscular, Injection
- Lenvatinib Mesylate-Tetanus, diphtheria, acellular pertussis vaccine Tdap
- Tetanus and Diphtheria Vaccine-Lenvima
- Tetanus and Diphtheria Vaccine-Lenvima (14 MG Daily Dose)
- Tetanus and Diphtheria Vaccine-Lenvima (18 MG Daily Dose)
- Tetanus and Diphtheria Vaccine-Lenvima (20 MG Daily Dose)
- Tetanus and Diphtheria Vaccine-Lenvima (24 MG Daily Dose)
- Tetanus and Diphtheria Vaccine-Lenvima (8 MG Daily Dose)